Income Statement - 4D Molecular Therapeutics, Inc. (FDMT)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 85.21 | 0.04 | 20.72 | 3.13 | 18.04 | 13.61 | 6.99 | 14.13 | 5.79 |
| Cost of revenue | 7.63 | 6.71 | 97.10 | 3.88 | 3.02 | 53.04 | 38.72 | 18.36 | 13.57 |
| Gross profit | 77.58 | 0.04 | -76.37 | 3.13 | 18.04 | -39.43 | -31.73 | -4.23 | -7.78 |
| Total operating expenses | 237.13 | 187.88 | 36.49 | 113.16 | 89.37 | 17.24 | 19.03 | 24.53 | 17.06 |
| Operating income | -159.55 | -187.84 | -112.87 | -110.03 | -71.33 | -56.66 | -50.76 | -10.40 | -11.27 |
| Non-operating income (net) | 19.44 | 26.97 | 12.03 | 2.54 | 0.02 | -0.03 | 1.46 | 0.85 | 0.05 |
| Income before tax | -140.11 | -160.87 | -100.84 | -107.49 | -71.32 | -56.69 | -49.31 | -9.55 | -11.22 |
| Income tax expense | 5.58 | -6.42 | -3.02 | -0.15 | 3.63 | 0.85 | -0.09 | ||
| Net income | -140.11 | -160.87 | -100.84 | -101.08 | -68.30 | -56.69 | -49.31 | -9.55 | -11.22 |
Show Quarterly Income Statement
Income Statement - 4D Molecular Therapeutics, Inc. (FDMT)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.05 | 85.09 | 0.09 | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.03 | -0.02 | 20.20 | 0.24 | 0.30 | 1.25 | 0.50 | 0.16 | 1.22 | 0.09 | 1.37 | 14.58 | 2.00 | -0.98 | 7.42 | 3.63 | 3.54 | 2.03 | 0.54 | 2.21 | 2.21 | 4.53 | 4.53 | 2.53 | 2.53 |
| Cost of revenue | 2.06 | 1.98 | 47.24 | 47.95 | 1.78 | 1.70 | 31.86 | 27.87 | 26.03 | 25.07 | 23.58 | 22.41 | 21.50 | 18.94 | 20.42 | 19.38 | 17.53 | 15.84 | 15.22 | 12.77 | 12.61 | 11.56 | 15.72 | 13.16 | 12.36 | 9.37 | 8.49 | 8.49 | 5.08 | 5.08 | 4.10 | 4.10 | |
| Gross profit | 0.99 | 83.11 | -47.15 | -47.94 | 0.01 | -1.78 | 0.00 | -31.86 | -27.84 | -26.05 | -4.86 | -23.35 | -22.11 | -20.25 | -18.44 | -20.26 | -18.16 | -17.44 | -14.47 | -0.64 | -10.77 | -13.58 | -4.13 | -12.09 | -9.62 | -10.33 | -8.83 | -6.28 | -6.28 | -0.55 | -0.55 | -1.57 | -1.57 |
| Total operating expenses | 74.61 | 68.40 | 14.04 | 11.52 | 53.64 | 54.33 | 51.14 | 10.60 | 10.29 | 10.61 | 9.11 | 8.79 | 7.99 | 8.47 | 8.06 | 8.17 | 8.23 | 7.33 | 8.19 | 6.95 | 5.54 | 6.84 | 3.68 | 3.06 | 3.65 | 18.32 | 12.43 | 2.45 | 2.45 | 1.99 | 1.99 | 1.10 | 1.10 |
| Operating income | -73.62 | 14.72 | -61.19 | -59.46 | -53.62 | -56.12 | -51.13 | -42.46 | -38.14 | -36.65 | -13.97 | -32.14 | -30.11 | -28.72 | -26.50 | -28.43 | -26.39 | -24.76 | -22.66 | -7.60 | -16.31 | -20.42 | -7.82 | -15.15 | -13.28 | -16.29 | -17.02 | -8.73 | -8.73 | -2.53 | -2.53 | -2.67 | -2.67 |
| Non-operating income (net) | 4.86 | 4.68 | 4.31 | 4.80 | 5.65 | 6.45 | 7.29 | 7.50 | 5.74 | 4.37 | 3.72 | 2.52 | 1.42 | 1.34 | 0.80 | 0.34 | 0.05 | -0.32 | 0.42 | 0.01 | -0.09 | -0.13 | -0.02 | 0.00 | 0.12 | 0.17 | 0.35 | 0.47 | 0.47 | 0.35 | 0.35 | 0.08 | 0.08 |
| Income before tax | -68.76 | 19.40 | -56.88 | -54.66 | -47.97 | -49.67 | -43.84 | -34.95 | -32.40 | -32.28 | -10.26 | -29.62 | -28.68 | -27.38 | -25.69 | -28.09 | -26.34 | -25.08 | -22.24 | -7.59 | -16.41 | -20.55 | -7.83 | -15.15 | -13.16 | -16.12 | -16.68 | -8.26 | -8.26 | -2.18 | -2.18 | -2.59 | -2.59 |
| Income tax expense | 0.00 | 0.00 | 6.73 | -3.88 | -1.43 | -1.42 | -0.11 | -1.60 | -0.68 | -0.15 | 0.31 | -0.44 | -0.01 | 0.00 | 0.00 | -0.01 | -0.13 | -0.22 | -0.34 | ||||||||||||||
| Net income | -68.76 | 19.40 | -56.88 | -54.66 | -47.97 | -49.67 | -43.84 | -34.95 | -32.40 | -32.28 | -10.26 | -29.62 | -28.68 | -27.38 | -25.69 | -28.09 | -26.34 | -25.08 | -22.24 | -7.59 | -16.41 | -20.55 | -7.83 | -15.15 | -13.16 | -16.12 | -16.68 | -8.26 | -8.26 | -2.18 | -2.18 | -2.59 | -2.59 |